A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HIV-PI / HIV protease inhibitors

[Related PubMed/MEDLINE]
Total Number of Papers: 12
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HIV-PI  (>> Co-occurring Abbreviation)
Long Form:   HIV protease inhibitors
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Lopinavir Loaded Spray Dried Liposomes with Penetration Enhancers for Cytotoxic Activity. ATR-FTIR, L-SDP, LPV
2018 The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies. CC, CIN, HIV, HPV, MMPs
2017 HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives? KS, NO
2014 Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations. PS
2014 The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells. HIV, IDV, MMP, MT, Sp
2013 Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance. p-AKT
2011 Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas. MMPs
2010 HIV protease inhibitors elicit volume-sensitive Cl- current in cardiac myocytes via mitochondrial ROS. ROS
2008 Possible allosteric interactions of monoindazole-substituted P2 cyclic urea analogues with wild-type and mutant HIV-1 protease. CMR, HIV-PR, QSAR
10  2007 HIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrest. CDK2
11  2005 From SAR to comparative QSAR: role of hydrophobicity in the design of 4-hydroxy-5,6-dihydropyran-2-ones HIV-1 protease inhibitors. ---
12  2004 Vascular endothelial toxicity induced by HIV protease inhibitor: evidence of oxidant-related dysfunction and apoptosis. HAART, NAC, SAQ